NORTHWEST BIOTHERAPEUTICS INC Operating Lease Liability
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Operating Lease Liability of $4.47 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $4.47M.
- 2026-03-31: Operating Lease, Liability $4.57M.
- 2025-12-31: Operating Lease, Liability $4.79M.
- 2025-09-30: Operating Lease, Liability $4.85M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $4.47M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.57M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $4.79M 10-K · filed 2026-04-15 | |
| 2025-09-30 | $4.85M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.07M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.86M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $4.76M 10-K · filed 2025-03-31 | |
| 2024-09-30 | $5.08M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.54M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $4.63M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $4.77M 10-K · filed 2024-03-05 | |
| 2023-09-30 | $4.50M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.75M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.74M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $4.72M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $4.47M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $4.90M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $5.33M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $5.54M 10-K · filed 2022-03-01 | |
| 2021-09-30 | $5.60M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $5.75M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $5.73M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $5.08M 10-K · filed 2021-03-31 | |
| 2020-09-30 | $4.90M 10-Q · filed 2021-01-15 | |
| 2020-06-30 | $4.80M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.79M 10-Q · filed 2020-08-10 | $4.90M 10-Q · filed 2020-06-24 |
| 2019-12-31 | $5.31M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $4.90M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $4.97M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $5.02M 10-Q · filed 2019-05-10 | |
| 2019-01-01 | $4.30M 10-K · filed 2022-03-01 |